Publication | Open Access
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146
14
Citations
24
References
2024
Year
NCT02501096.
| Year | Citations | |
|---|---|---|
Page 1
Page 1